Concepedia

Publication | Open Access

HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

DOIFull Paper Access

31

Citations

36

References

2022

Year

Jie Mei, Guanyu Jiang, Yundi Chen, Yongrui Xu, Yuan Wan, Ruo Chen, Feng Liu, Wenjun Mao, Mingfeng Zheng, Junying Xu
BMC Cancer

Abstract

Overall, HLA-DRA could be a promising biomarker for guiding ICB in NSCLC.

References

YearCitations

Page 1